The trademark OCTRUIS was filed by BioMarin Pharmaceutical Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on February 9, 2020, and received one opposition filed on May 17, 2020 by Amryt Endo, Inc. on Likelihood of confusion. the opponent was represented by KILBURN & STRODE LLP and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 17, 2020
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).